Epichem Supporting WA Innovators Applying for the FHRI Innovation Seed Fund 2025–26
James Rixson
Epichem Supporting WA Innovators Applying for the FHRI Innovation Seed Fund 2025–26
Epichem Supporting WA Innovators Applying for the FHRI Innovation Seed Fund 2025–26
The Future Health Research and Innovation (FHRI) Fund has opened the Innovation Seed Fund 2025–26, offering up to $1.5 million to help WA innovators develop and commercialise new health technologies - including novel therapeutics, vaccines, diagnostics, devices and digital health solutions.
If your project involves small molecules, medicinal chemistry or chemistry-driven innovation, Epichem can help strengthen your proposal and deliver the chemistry required for early-stage development.
How Epichem Supports FHRI Applicants
As a 100% WA-based CRO, Epichem can act as a subcontractor or collaboration partner for ISF applicants, delivering high-quality small-molecule chemistry from our Perth laboratories.
We can support your application with:
Hit-to-lead & lead optimisation for small-molecule therapeutics
WA-based R&D, aligning with FHRI’s requirement to build and retain capability within the State
Fast scoping & budgeting for grant applications
Our team can help you articulate realistic chemistry work packages, timelines and costings for your application - ensuring your proposal is competitive and technically sound.
Funding & Key Dates
Grant Amounts: Up to $1.5M (depending on project stream)
Who Can Apply: WA-based innovators developing devices, diagnostics, digital health, therapeutics or vaccines
